Pharmacotherapy For Cardiovascular Disorders | Cheap Nursing Papers

Pharmacotherapy For Cardiovascular Disorders

Pharmacotherapy For Cardiovascular Disorders

This is a case study. The main textbook for this course is : 

 

Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.

 

I need additional scholarly and current references as well.  Below you will find the case study and required questions to be answered about this case study. Thank you!

 

  • Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
  •  
  • Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.
  •  
  • Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.
  •  
  • Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. 
  •  
  • Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.
  •  

Write a 2- to 3-page paper that addresses the following:

  • Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
  •  
  • Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
  •  
  • Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.

 

Would you discontinue any medications, change the dosage, and/or add medications to the patient’s regimen? DISCUSS EACH MEDICATION.

 

 

 

CASE STUDY:

 

Case study assigned

LM is an 89-year-old female resident of a long-term care facility who has been experiencing multiple falls, some resulting in injuries such as bruising and skin tears. Over the last 6 months, her ambulation status has declined from independent to wheelchair level. She complains of pain in her legs when walking more than short distances across the nursing unit.

 

PMH:

  • HTN
  • Alzheimer’s disease
  • Hypothyroidism
  • Osteoarthritis
  • Diabetes

 

MEDICATIONS:

  • Amlodipine 10 mg QD
  • Donepezil 10 mg QHS
  • Levothyroxine 88 mcg QAM
  • Celecoxib 200 mg QD
  • Furosemide 40 mg QAM
  • Metformin 500mg, 1 BID
  • Glyburide 5mg, 1 BID

 

ALLERGIES: NKA

 

SOCIAL HISTORY:

Widowed with 2 adult children living in town, retired photographer and owner of an art supply store

 

VITALS:                                             LABS:

Weight: 129 lbs                               TSH 2.45, Free T4 0.98

Height: 64 inches                            Na 135, K+ 3.4, Cl 99, CO2 25,

BP: Supine = 177/82                       Glucose 101

HR: 78 bpm                                      WBC 7.0, RBC 4.5, Hgb 11.9, Hct 34.1, Plt 255

                                                           BUN 42, Cr 1.6, UA Clear

                                                           eGFR: 45 ml/min

PE:

  • HEENT: Normocephalic, no evidence of trauma, PERRLA, EOMI
  • CV: RRR
  • Respiratory: Clear to auscultation bilaterally
  • Abdomen: Soft, non-tender, no masses or guarding
  • G/U: Skin intact, assisted with toileting and personal hygiene by staff
  • Extremities: Bilateral 2+ edema to lower extremities; skin dry, dark bruising and skin tear to right elbow and forearm
  • Neuro: Alert and oriented to person only. MMSE 18/30, stable over last 12 months

 

PAIN ASSESSMENT:

Faces pain scale: No pain occurs at rest, upon walking, pain is moderate to severe

 

"Get 15% discount on your first 3 orders with us"
Use the following coupon
FIRST15

Order Now

Pharmacotherapy for Cardiovascular Disorders

Pharmacotherapy for Cardiovascular Disorders

    …heart disease remains the No. 1 killer in America; nearly half of all Americans have high blood pressure, high cholesterol, or smoke—some of the leading risk factors for heart disease…

    —Murphy et al., 2018

    Despite the high mortality rates associated with cardiovascular disorders, improved treatment options do exist that can help address those risk factors that afflict the majority of the population today.

    As an advanced practice nurse, it is your responsibility to recommend appropriate treatment options for patients with cardiovascular disorders. To ensure the safety and effectiveness of drug therapy, advanced practice nurses must consider aspects that might influence pharmacokinetic and pharmacodynamic processes such as medical history, other drugs currently prescribed, and individual patient factors.

Reference: Murphy, S. L., Xu, J., Kochanek, K. D., & Arias, E. (2018). Mortality in the United States, 2017. Retrieved from https://www.cdc.gov/nchs/products/databriefs/db328…

To Prepare
  • Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.
  • Review the case study assigned by your Instructor for this Assignment.
  • Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
  • Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.
  • Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.
  • Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.
By Day 7 of Week 2

Write a 2- to 3-page paper that addresses the following:

  • Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
  • Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
  • Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.

The scenarios for your assignment this week are listed below. Please choose ONE of these topics.

Case Study 1:

Patient AO is a 50 year-old African-American male that has a history of obesity and has recently gained 9 pounds. The patient has been diagnosed with hypertension and hyperlipidemia. Drugs currently prescribed include the following:

  • Atenolol 12.5 mg daily
  • Hydralazine 10 mg qid
  • Sertraline 25 mg daily
  • Simvastatin 80 mg daily

Case Study 2:

Patient CB is an 88 year-old female with a history of strokes. The patient has been diagnosed with type 2 diabetes, hypertension, and hyperlipidemia. Drugs currently prescribed include the following:

  • Glipizide 10 mg po daily
  • HCTZ 25 mg daily
  • Atenolol 25 mg po daily
  • Simvastatin 80 mg daily
  • Verapamil 180 mg CD daily

"Get 15% discount on your first 3 orders with us"
Use the following coupon
FIRST15

Order Now

Hi there! Click one of our representatives below and we will get back to you as soon as possible.

Chat with us on WhatsApp